Literature DB >> 12379731

Parenteral administration of medium- but not long-chain lipid emulsions may increase the risk for infections by Candida albicans.

Geert J Wanten1, Mihai G Netea, Ton H Naber, Jo H Curfs, Liesbeth E Jacobs, Trees J Verver-Jansen, Bart-Jan Kullberg.   

Abstract

Intravenous administration to volunteers of an emulsion of medium-chain lipids, but not of an emulsion of pure long-chain lipids or a placebo, increased the growth of Candida albicans in serum and modulated Candida-induced cytokine production by mononuclear cells in a way suggesting that medium-chain, but not long-chain, triglycerides increase the risk for infections by Candida.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379731      PMCID: PMC130431          DOI: 10.1128/IAI.70.11.6471-6474.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

Review 1.  Immunity to intracellular microbial pathogens.

Authors:  S H Kaufmann
Journal:  Immunol Today       Date:  1995-07

2.  Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans.

Authors:  M G Netea; L J van Tits; J H Curfs; F Amiot; J F Meis; J W van der Meer; B J Kullberg
Journal:  J Immunol       Date:  1999-08-01       Impact factor: 5.422

3.  Functional alterations of human neutrophils by medium-chain triglyceride emulsions: evaluation of phagocytosis, bacterial killing, and oxidative activity.

Authors:  R Bellinati-Pires; D L Waitzberg; M M Salgado; M M Carneiro-Sampaio
Journal:  J Leukoc Biol       Date:  1993-04       Impact factor: 4.962

4.  Long-chain predominant lipid emulsions inhibit in vitro macrophage tumor necrosis factor production.

Authors:  W D Vazquez; G Arya; V F Garcia
Journal:  JPEN J Parenter Enteral Nutr       Date:  1994 Jan-Feb       Impact factor: 4.016

5.  Medium- and long-chain triglycerides have different effects on the synthesis of tumor necrosis factor by human mononuclear cells in patients under total parenteral nutrition.

Authors:  C A Gogos; N Zoumbos; M Makri; F Kalfarentzos
Journal:  J Am Coll Nutr       Date:  1994-02       Impact factor: 3.169

6.  Survival to lipopolysaccharide, cytokine release and phagocyte functions in mice treated with different total parenteral nutrition regimens.

Authors:  M A Tufano; F Rossi; F Rossano; P Catalanotti; L Stella; G Servillo; R Tufano
Journal:  Immunopharmacol Immunotoxicol       Date:  1995-08       Impact factor: 2.730

7.  Interleukin-4 and -10 exacerbate candidiasis in mice.

Authors:  L Tonnetti; R Spaccapelo; E Cenci; A Mencacci; P Puccetti; R L Coffman; F Bistoni; L Romani
Journal:  Eur J Immunol       Date:  1995-06       Impact factor: 5.532

8.  Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-alpha and IL-1 beta production.

Authors:  J P Drenth; S H Van Uum; M Van Deuren; G J Pesman; J Van der Ven-Jongekrijg; J W Van der Meer
Journal:  J Appl Physiol (1985)       Date:  1995-11

Review 9.  Interleukin-8 and the chemokine family.

Authors:  M Baggiolini; P Loetscher; B Moser
Journal:  Int J Immunopharmacol       Date:  1995-02

10.  Parenteral nutrition alters monocyte TNF receptor activity.

Authors:  C C Braxton; S M Coyle; W J Montegut; T van der Poll; M Roth; S E Calvano; S F Lowry
Journal:  J Surg Res       Date:  1995-07       Impact factor: 2.192

View more
  3 in total

1.  Targeted gene deletion in Candida parapsilosis demonstrates the role of secreted lipase in virulence.

Authors:  Attila Gácser; David Trofa; Wilhelm Schäfer; Joshua D Nosanchuk
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

2.  Lipase 8 affects the pathogenesis of Candida albicans.

Authors:  Attila Gácser; Frank Stehr; Cathrin Kröger; László Kredics; Wilhelm Schäfer; Joshua D Nosanchuk
Journal:  Infect Immun       Date:  2007-07-23       Impact factor: 3.441

3.  Disparate Candida albicans Biofilm Formation in Clinical Lipid Emulsions Due to Capric Acid-Mediated Inhibition.

Authors:  Hubertine M E Willems; Jeremy S Stultz; Molly E Coltrane; Jabez P Fortwendel; Brian M Peters
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.